APA

Karnitz L. M., Flatten K. S., Wagner J. M., Loegering D., Hackbarth J. S., Arlander S. J. H., Vroman B. T., Thomas M. B., Baek Y., Hopkins K. M., Lieberman H. B., Chen J., Cliby W. A. & Kaufmann S. H. (20060119). Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival. : Molecular pharmacology.

Chicago

Karnitz Larry M, Flatten Karen S, Wagner Jill M, Loegering David, Hackbarth Jennifer S, Arlander Sonnet J H, Vroman Benjamin T, Thomas M Bijoy, Baek Yong-Un, Hopkins Kevin M, Lieberman Howard B, Chen Junjie, Cliby William A and Kaufmann Scott H. 20060119. Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival. : Molecular pharmacology.

Harvard

Karnitz L. M., Flatten K. S., Wagner J. M., Loegering D., Hackbarth J. S., Arlander S. J. H., Vroman B. T., Thomas M. B., Baek Y., Hopkins K. M., Lieberman H. B., Chen J., Cliby W. A. and Kaufmann S. H. (20060119). Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival. : Molecular pharmacology.

MLA

Karnitz Larry M, Flatten Karen S, Wagner Jill M, Loegering David, Hackbarth Jennifer S, Arlander Sonnet J H, Vroman Benjamin T, Thomas M Bijoy, Baek Yong-Un, Hopkins Kevin M, Lieberman Howard B, Chen Junjie, Cliby William A and Kaufmann Scott H. Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival. : Molecular pharmacology. 20060119.